-
Je něco špatně v tomto záznamu ?
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study
G. Brambilla, M. Bombelli, G. Seravalle, R. Cifkova, S. Laurent, K. Narkiewicz, R. Facchetti, J. Redon, G. Mancia, G. Grassi,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem
- MeSH
- antihypertenziva terapeutické užití MeSH
- dospělí MeSH
- hodnoty glomerulární filtrace MeSH
- hypertenze farmakoterapie epidemiologie MeSH
- index tělesné hmotnosti MeSH
- kardiovaskulární nemoci komplikace farmakoterapie epidemiologie MeSH
- krevní tlak MeSH
- léková rezistence * MeSH
- lidé středního věku MeSH
- lidé MeSH
- měření krevního tlaku MeSH
- obezita komplikace MeSH
- prevalence MeSH
- průřezové studie MeSH
- renální insuficience komplikace MeSH
- rizikové faktory MeSH
- senioři MeSH
- syndrom bílého pláště diagnóza epidemiologie MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- východní Evropa MeSH
OBJECTIVE: Scanty information is available on the clinical characteristics of resistant hypertension in Central and East European countries. The Blood Pressure (BP) control rate and CArdiovascular Risk profilE (BP-CARE) study allowed us to assess the prevalence and the main clinical features of resistant hypertension in this population. DESIGN AND METHOD: The study was carried out in 1312 treated hypertensive patients living in nine Central and East European countries. RESULTS: Four hundred and twenty-three patients had apparent resistant hypertension, of whom 168 had pseudo-resistant hypertension (noncompliant/white-coat) and 255 were true treatment-resistant hypertension patients (TRH). Clinical BP values in TRH amounted to 157.4±16.9/91.8±10.0 mmHg despite the daily use of 3.6±0.7 drugs. Their 24-h BP values were 149.5±16.5/97.5±9.8 mmHg. Compared to controlled hypertensive patients (n=368) and uncontrolled nonresistant hypertensive patients (n=521), TRH were older with a greater prevalence of women. They showed a higher rate of previous cardiovascular events and a very high cardiovascular risk profile. Estimated glomerular filtration rate was significantly lower in TRH as compared to controlled hypertensive patients and uncontrolled nonresistant hypertensive patients. Overall, target organ damage was more frequently detected in TRH than in controlled hypertensive patients and uncontrolled nonresistant hypertensive patients. The factor most frequently associated with TRH was severity of hypertension followed by age, total cholesterol, BMI and history of heart failure. CONCLUSIONS: The present study provides evidence that the prevalence of TRH in Central and East European countries is similar to that found in Western Europe and USA. It also shows the very high cardiovascular risk of TRH and the elevated association of this condition with obesity, renal failure, organ damage and history of cardiovascular events.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14064113
- 003
- CZ-PrNML
- 005
- 20140708123430.0
- 007
- ta
- 008
- 140704s2013 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/HJH.0b013e328363823f $2 doi
- 035 __
- $a (PubMed)23838657
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Brambilla, Gianmaria $u aClinica Medica, Università Milano-Bicocca, Ospedale San Gerardo dei Tintori, Monza bIstituto Auxologico Italiano, Ospedale San Luca, Milan, Italy cCenter for Cardiovascular Prevention, Thomayer Hospital and Department of Preventive Cardiology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic dPharmacology Department and INSERM U970 Hopital Europeen Georges Pompidou, Assistance-Publique Hopitaux de Paris, Paris-Derscartes University, France eDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland fInternal Medicine, Hospital Clinico, University of Valencia, Valencia, Spain gIRCCS MultiMedica, Sesto San Giovanni, Milan, Italy.
- 245 10
- $a Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study / $c G. Brambilla, M. Bombelli, G. Seravalle, R. Cifkova, S. Laurent, K. Narkiewicz, R. Facchetti, J. Redon, G. Mancia, G. Grassi,
- 520 9_
- $a OBJECTIVE: Scanty information is available on the clinical characteristics of resistant hypertension in Central and East European countries. The Blood Pressure (BP) control rate and CArdiovascular Risk profilE (BP-CARE) study allowed us to assess the prevalence and the main clinical features of resistant hypertension in this population. DESIGN AND METHOD: The study was carried out in 1312 treated hypertensive patients living in nine Central and East European countries. RESULTS: Four hundred and twenty-three patients had apparent resistant hypertension, of whom 168 had pseudo-resistant hypertension (noncompliant/white-coat) and 255 were true treatment-resistant hypertension patients (TRH). Clinical BP values in TRH amounted to 157.4±16.9/91.8±10.0 mmHg despite the daily use of 3.6±0.7 drugs. Their 24-h BP values were 149.5±16.5/97.5±9.8 mmHg. Compared to controlled hypertensive patients (n=368) and uncontrolled nonresistant hypertensive patients (n=521), TRH were older with a greater prevalence of women. They showed a higher rate of previous cardiovascular events and a very high cardiovascular risk profile. Estimated glomerular filtration rate was significantly lower in TRH as compared to controlled hypertensive patients and uncontrolled nonresistant hypertensive patients. Overall, target organ damage was more frequently detected in TRH than in controlled hypertensive patients and uncontrolled nonresistant hypertensive patients. The factor most frequently associated with TRH was severity of hypertension followed by age, total cholesterol, BMI and history of heart failure. CONCLUSIONS: The present study provides evidence that the prevalence of TRH in Central and East European countries is similar to that found in Western Europe and USA. It also shows the very high cardiovascular risk of TRH and the elevated association of this condition with obesity, renal failure, organ damage and history of cardiovascular events.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a antihypertenziva $x terapeutické užití $7 D000959
- 650 _2
- $a krevní tlak $7 D001794
- 650 _2
- $a měření krevního tlaku $7 D001795
- 650 _2
- $a index tělesné hmotnosti $7 D015992
- 650 _2
- $a kardiovaskulární nemoci $x komplikace $x farmakoterapie $x epidemiologie $7 D002318
- 650 _2
- $a průřezové studie $7 D003430
- 650 12
- $a léková rezistence $7 D004351
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hodnoty glomerulární filtrace $7 D005919
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypertenze $x farmakoterapie $x epidemiologie $7 D006973
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a obezita $x komplikace $7 D009765
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a renální insuficience $x komplikace $7 D051437
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a syndrom bílého pláště $x diagnóza $x epidemiologie $7 D059466
- 651 _2
- $a východní Evropa $x epidemiologie $7 D005061
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bombelli, Michele
- 700 1_
- $a Seravalle, Gino
- 700 1_
- $a Cifkova, Renata
- 700 1_
- $a Laurent, Stephane
- 700 1_
- $a Narkiewicz, Krzysztof
- 700 1_
- $a Facchetti, Rita
- 700 1_
- $a Redon, Josep
- 700 1_
- $a Mancia, Giuseppe
- 700 1_
- $a Grassi, Guido
- 773 0_
- $w MED00002723 $t Journal of hypertension $x 1473-5598 $g Roč. 31, č. 10 (2013), s. 2018-24
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23838657 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140704 $b ABA008
- 991 __
- $a 20140708123720 $b ABA008
- 999 __
- $a ok $b bmc $g 1031597 $s 862845
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 31 $c 10 $d 2018-24 $i 1473-5598 $m Journal of hypertension $n J Hypertens $x MED00002723
- LZP __
- $a Pubmed-20140704